Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3508)

Athanassios Argiris, J. W. Lee, J. Stevenson, M. G. Sulecki, V. Hugec, N. W. Choong, J. N. Saltzman, W. Song, R. M. Hansen, T. L. Evans, S. S. Ramalingam, J. H. Schiller

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3508)'. Together they form a unique fingerprint.

Medicine & Life Sciences